Skip to main content

Design Therapeutics, Inc.

DSGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001807120

No open-market purchases or sales by Design Therapeutics, Inc. insiders were filed in the last 90 days; 136 institutions reported holding it in 13F filings for Q2 2026, worth $626.4M in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in Design Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
52
+2 vs. Q2 2021
Shares held
28.3M
+442.2K (+1.6%) vs. Q2 2021
Total value
$414.8M
−$131.4M (−24.1%) vs. Q2 2021
New holders
3
23 more added
Sold out
1
11 more reduced

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DSGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 52 institutions
Q1 2021: 43 institutionsQ2 2021: 50 institutionsQ3 2021: 52 institutionsQ4 2021: 60 institutionsQ1 2022: 63 institutionsQ2 2022: 74 institutionsQ3 2022: 79 institutionsQ4 2022: 83 institutionsQ1 2023: 96 institutionsQ2 2023: 97 institutionsQ3 2023: 87 institutionsQ4 2023: 88 institutionsQ1 2024: 93 institutionsQ2 2024: 95 institutionsQ3 2024: 100 institutionsQ4 2024: 95 institutionsQ1 2025: 98 institutionsQ2 2025: 93 institutionsQ3 2025: 95 institutionsQ4 2025: 117 institutionsQ1 2026: 125 institutionsQ2 2026: 136 institutions
Value heldQ3 2021: $414.8M
Q1 2021: $755.2MQ2 2021: $546.2MQ3 2021: $414.8MQ4 2021: $773.1MQ1 2022: $613.7MQ2 2022: $541.7MQ3 2022: $667.2MQ4 2022: $414.2MQ1 2023: $223.3MQ2 2023: $244.4MQ3 2023: $77.6MQ4 2023: $84.0MQ1 2024: $123.9MQ2 2024: $107.5MQ3 2024: $172.3MQ4 2024: $206.5MQ1 2025: $133.0MQ2 2025: $116.4MQ3 2025: $259.7MQ4 2025: $357.6MQ1 2026: $404.1MQ2 2026: $626.4M
Institutions holding DSGN and their total value by quarter
QuarterHoldersValue
Q2 2026136$626.4M
Q1 2026125$404.1M
Q4 2025117$357.6M
Q3 202595$259.7M
Q2 202593$116.4M
Q1 202598$133.0M
Q4 202495$206.5M
Q3 2024100$172.3M
Q2 202495$107.5M
Q1 202493$123.9M
Q4 202388$84.0M
Q3 202387$77.6M
Q2 202397$244.4M
Q1 202396$223.3M
Q4 202283$414.2M
Q3 202279$667.2M
Q2 202274$541.7M
Q1 202263$613.7M
Q4 202160$773.1M
Q3 202152$414.8M
Q2 202150$546.2M
Q1 202143$755.2M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Design Therapeutics, Inc.; share changes are against Q2 2021.

Institutions holding DSGN in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Cormorant Asset Management, LP5,364,850$78.8M3.20%−50,000−0.9%Reduced
Logos Global Management LP2,772,501$40.7M2.94%+40,000+1.5%Added
Citadel Advisors LLC2,572,530$37.8M0.04%+6,382+0.2%Added
Ra Capital Management, L.P.2,186,636$32.1M0.45%00.0%Unchanged
EcoR1 Capital, LLC1,863,098$27.4M0.97%+603,079+47.9%Added
Avoro Capital Advisors LLC1,468,318$21.6M0.34%00.0%Unchanged
Price T Rowe Associates Inc1,448,968$21.3M0.00%00.0%Unchanged
Baker Bros. Advisors LP1,436,636$21.1M0.09%00.0%Unchanged
BlackRock Inc.1,312,664$19.3M0.00%−90,678−6.5%Reduced
Vanguard Group Inc1,088,201$16.0M0.00%−117,765−9.8%Reduced
FMR LLC1,000,000$14.7M0.00%00.0%Unchanged
Wellington Management Group LLP955,588$14.0M0.00%+16,226+1.7%Added
Janus Henderson Group PLC936,659$13.1M0.01%+90.0%Added
Vivo Capital, LLC530,991$7.80M0.35%00.0%Unchanged
Artal Group S.A.400,000$5.88M0.14%00.0%Unchanged
Eventide Asset Management, LLC400,000$5.88M0.08%00.0%Unchanged
Rock Springs Capital Management LP334,050$4.91M0.10%+2,000+0.6%Added
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)280,991$4.13M0.05%00.0%Unchanged
Geode Capital Management, LLC258,032$3.79M0.00%+5,272+2.1%Added
Credit Suisse AG235,938$3.47M0.00%−4,220−1.8%Reduced
Principal Financial Group Inc220,510$3.24M0.00%+9,008+4.3%Added
State Street Corp211,608$3.11M0.00%+23,519+12.5%Added
Norges Bank200,000$2.94M0.00%00.0%Unchanged
Adage Capital Partners GP, L.L.C.165,000$2.42M0.00%+119,888+265.8%Added
Northern Trust Corp122,832$1.80M0.00%−12,695−9.4%Reduced
Charles Schwab Investment Management Inc90,521$1.33M0.00%+2,756+3.1%Added
TD Asset Management Inc65,718$965.0K0.00%+44,396+208.2%Added
Goldman Sachs Group Inc55,134$810.0K0.00%+34,056+161.6%Added
Ensign Peak Advisors, Inc50,000$735.0K0.00%00.0%Unchanged
Nuveen Asset Management, LLC43,045$696.0K0.00%−468−1.1%Reduced
Bank of New York Mellon Corp36,476$536.0K0.00%+2,979+8.9%Added
Bank of America Corp31,630$465.0K0.00%+25,228+394.1%Added
Citigroup Inc24,808$364.0K0.00%+1,118+4.7%Added
State of Wisconsin Investment Board17,400$256.0K0.00%00.0%Unchanged
Octagon Capital Advisors LP14,926$219.0K0.05%−235,074−94.0%Reduced
Millennium Management LLC14,169$208.0K0.00%+14,169New
New York State Common Retirement Fund11,738$172.0K0.00%+138+1.2%Added
Rhumbline Advisers10,589$156.0K0.00%+10,589New
JPMorgan Chase & Co8,137$120.0K0.00%+142+1.8%Added
Deutsche Bank AG8,015$118.0K0.00%+15+0.2%Added
American International Group, Inc.7,623$112.0K0.00%+72+1.0%Added
Morgan Stanley7,404$108.0K0.00%+6,757+1,044.4%Added
California State Teachers Retirement System7,242$106.0K0.00%−11,357−61.1%Reduced
Piper Sandler & Co.2,500$37.0K0.05%+2,500New
STRS Ohio2,000$29.0K0.00%−1,100−35.5%Reduced
Royal Bank of Canada1,590$23.0K0.00%+668+72.5%Added
Legal & General Group Plc1,276$19.0K0.00%00.0%Unchanged
UBS Group AG1,134$17.0K0.00%+636+127.7%Added
Ameritas Investment Partners, Inc.1,057$16.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)446$7.00K0.00%−1,683−79.1%Reduced
Advisor Group Holdings, Inc.96$2.00K0.00%00.0%Unchanged
State of Wyoming81$1.00K0.00%−40−33.1%Reduced
Pinz Capital Management, LP0$00.00%−4,338−100.0%Sold out